Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk

M Ahmad, LB Weiswald, L Poulain, C Denoyelle… - Journal of Experimental …, 2023 - Springer
Cancer is the main cause of death worldwide and metastasis is a major cause of poor
prognosis and cancer-associated mortality. Metastatic conversion of cancer cells is a …

Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating …

NM El-Sheikh, AI Abulsoud, EF Wasfey… - Pathology-Research and …, 2022 - Elsevier
Long non-coding RNAs (lncRNAs) are becoming more prevalent in the cancer field arena,
with functional roles in both oncogenic and onco-suppressive pathways. Despite their …

The role of epigenetic modifications in human cancers and the use of natural compounds as epidrugs: Mechanistic pathways and pharmacodynamic actions

A Bouyahya, H Mechchate, L Oumeslakht, I Zeouk… - Biomolecules, 2022 - mdpi.com
Cancer is a complex disease resulting from the genetic and epigenetic disruption of normal
cells. The mechanistic understanding of the pathways involved in tumor transformation has …

Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in …

N Li, X Zhan - EPMA Journal, 2019 - Springer
Relevance The pathogenesis and biomarkers of ovarian cancer (OC) remain not well-known
in diagnosis, effective therapy, and prognostic assessment in OC personalized medicine …

Crosstalk between RNA m6A modification and non-coding RNA contributes to cancer growth and progression

F Dai, Y Wu, Y Lu, C An, X Zheng, L Dai, Y Guo… - … Therapy-Nucleic Acids, 2020 - cell.com
N6-methyladenosine (m 6 A) is the most common RNA modification and has an important
role in normal development and tumorigenesis. The abnormal expression of m 6 A …

Tumor-derived exosomal long noncoding RNA LINC01133, regulated by Periostin, contributes to pancreatic ductal adenocarcinoma epithelial-mesenchymal transition …

Y Liu, T Tang, X Yang, P Qin, P Wang, H Zhang, M Bai… - Oncogene, 2021 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal malignancies and rapidly
progressive diseases. Exosomes and long noncoding RNAs (lncRNAs) are emerging as …

The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism

Y Xu, M Qiu, M Shen, S Dong, G Ye, X Shi, M Sun - Molecular Therapy, 2021 - cell.com
Compared to normal cells, cancer cells exhibit specific metabolic characteristics that
facilitate the growth and metastasis of cancer. It is now widely appreciated that long non …

Long non-coding RNAs: an overview on miRNA sponging and its co-regulation in lung cancer

S Rajakumar, S Jamespaulraj, Y Shah… - Molecular biology …, 2023 - Springer
Lung cancer is the most devastating cause of death among all cancers worldwide, and non-
small cell lung cancer (NSCLC) accounts for 80% of all the lung cancer cases. Beyond …

[HTML][HTML] The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development

C Zhang, S Wei, S Dai, X Li, H Wang… - … for immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Tumor-associated macrophages (TAMs) are a major component of the tumor
microenvironment (TME) and exert an important role in tumor progression. Due to the …

Identification of candidate biomarkers and analysis of prognostic values in oral squamous cell carcinoma

G Huang, Q Wu, Z Zheng, T Shao, XZ Lv - Frontiers in oncology, 2019 - frontiersin.org
Objectives: Oral squamous cell carcinoma (OSCC) is the most common oral cancer with a
poor prognosis owing to limited understanding of the disease mechanisms. The aim of this …